European Leukemia Trial Registry
Trial: BUM-5/GVH

More Details
Title Efficacy and Safety Study of Budesonide to Treat Oral Chronic GvHD
Scientific Title Double-blind, Randomised, Placebo-controlled Multicentre Phase III Clinical Study Followed by Open-label Phase on the Efficacy and Tolerability of Budesonide 3 mg Effervescent Tablet in Patients With Resistant Oral Chronic GvHD
Short Title BUM-5/GVH
Trialgroup NN
Type of Trial multicentric, randomized, prospective, double-blind, double-group
Disease Miscellaneous(Miscellaneous) Supportive Care
Age <= 75 years
Status No longer recruiting
Start of Recruitment 01.04.2009
Leader Wolff, Prof. Dr., Daniel
Shortprotocol Shortprotocol
created 01.10.2012 Sina Hehn
changed 20.03.2015 Hanna Ebert
ELIC European Leukemia Information Center | no responsibility is taken for correctness and completeness of this information | |